Bismuth-dimercaprol exposes surface components of Klebsiella pneumoniae camouflaged by the polysaccharide capsule.
Domenico
P
P
Winthrop-University Hospital, Mineola, New York 11501, USA.
Tomas
J M
JM
Merino
S
S
Rubires
X
X
Cunha
B A
BA
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000911:Antibodies, Monoclonal / Q000276:immunology; D016667:Bacterial Capsules / Q000096:biosynthesis / Q000187:drug effects*; D001729:Bismuth / Q000494:pharmacology*; D001770:Blood Bactericidal Activity / Q000187:drug effects; D003165:Complement System Proteins / Q000276:immunology; D004112:Dimercaprol / Q000031:analogs & derivatives* / Q000494:pharmacology*; D004338:Drug Combinations; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects* / Q000276:immunology; D009504:Neutrophils / Q000276:immunology; D019081:O Antigens / Q000276:immunology; D009942:Organometallic Compounds / Q000494:pharmacology*; D010587:Phagocytosis / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D004338:Drug Combinations; D019081:O Antigens; D009942:Organometallic Compounds; C103324:bismuth dimercaptopropanol; D004112:Dimercaprol; D003165:Complement System Proteins; D001729:Bismuth